The Science Underlying COVID-19: Implications for the Cardiovascular System

Circulation

Volumn 142, Issue 1, 2020, Pages 68-78

  Liu, Peter P ^a,b   Blet, Alice ^a,c,d   Smyth, David ^a,b   Li, Hongliang ^e  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d APHP   (France)

^e WUHAN UNIVERSITY   (China)

Author keywords

angiotensin converting enzyme 2; heart failure; human coronavirus; inflammation; myocarditis; severe acute respiratory syndrome; vasculitis

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 6; SERINE PROTEINASE; TMPRSS2 PROTEIN, HUMAN;

BETACORONAVIRUS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPLICATION; CORONAVIRUS INFECTION; CYTOLOGY; FEMALE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; ISOLATION AND PURIFICATION; LYMPHOCYTOPENIA; MALE; METABOLISM; MORTALITY; PANDEMIC; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; PROGNOSIS; SURVIVAL RATE; VIROLOGY; VIRUS PNEUMONIA;

BETACORONAVIRUS; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; LYMPHOPENIA; MALE; PANDEMICS; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; PNEUMONIA, VIRAL; PROGNOSIS; SERINE ENDOPEPTIDASES; SURVIVAL RATE;

EID: 85085024774     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.120.047549     Document Type: Article

References (68)

1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, China Novel Coronavirus Investigating and Research Team A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020 382 727 733. doi: 10.1056/NEJMoa2001017
2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 579 270 273. doi: 10.1038/s41586-020-2012-7
3. Bonow RO, Fonarow GC, O'Gara PT, Yancy CW, Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality [published online March 27, 2020]. JAMA Cardiol. doi: 10.1001/jamacardio.2020.1105. https://jamanetwork.com/journals/jamacardiology/fullarticle/2763844
4. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) [published online March 27, 2020]. JAMA Cardiol. doi: 10.1001/jamacardio.2020.1096. https://jamanetwork.com/journals/jamacardiology/fullarticle/2763843
5. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z, Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) [published online March 27, 2020]. JAMA Cardiol. doi: 10.1001/jamacardio.2020.1017. https://jamanetwork.com/journals/jamacardiology/fullarticle/2763845
6. Lippi G, Lavie CJ, Sanchis-Gomar F, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis [published online March 10, 2020]. Prog Cardiovasc Dis. doi: 10.1016/j.pcad.2020.03.001. https://www.sciencedirect.com/science/article/pii/S0033062020300554
7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China [published online March 25, 2020]. JAMA Cardiol. doi: 10.1001/jamacardio.2020.0950. https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524
8. Chapman AR, Bularga A, Mills NL, High-sensitivity cardiac troponin can be an ally in the fight against COVID-19 [published online April 6, 2020]. Circulation. doi: 10.1161/CIRCULATIONAHA.120.047008. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047008
9. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation 2020 141 1648 1655. doi: 10.1161/CIRCULATIONAHA.120.046941
10. Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 2020 581 215 220. doi: 10.1038/s41586-020-2180-5
11. Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F, Structural basis of receptor recognition by SARS-CoV-2. Nature 2020 581 221 224. doi: 10.1038/s41586-020-2179-y
12. Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E, The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020 176 104742. doi: 10.1016/j.antiviral.2020.104742
13. Grubaugh ND, Ladner JT, Lemey P, Pybus OG, Rambaut A, Holmes EC, Andersen KG, Tracking virus outbreaks in the twenty-first century. Nat Microbiol 2019 4 10 19. doi: 10.1038/s41564-018-0296-2
14. Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C, Virological assessment of hospitalized patients with COVID-2019. Nature 2020 581 465 469. doi: 10.1038/s41586-020-2196-x
15. Fauci AS, Lane HC, Redfield RR, Covid-19-navigating the uncharted. N Engl J Med 2020 382 1268 1269. doi: 10.1056/NEJMe2002387
16. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020 395 1054 1062. doi: 10.1016/S0140-6736(20)30566-3
17. Tian H, Liu Y, Li Y, Wu CH, Chen B, Kraemer MUG, Li B, Cai J, Xu B, An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science 2020 368 638 642. doi: 10.1126/science.abb6105
18. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018 378 345 353
19. Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013 310 1711 1720
20. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J, SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 2009 39 618 625. doi: 10.1111/j.1365-2362.2009.02153.x
21. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020 181 281 292.e6. doi: 10.1016/j.cell.2020.02.058
22. Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020 181 271 280.e8. doi: 10.1016/j.cell.2020.02.052
23. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003 426 450 454. doi: 10.1038/nature02145
24. Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A 2020 117 7001 7003. doi: 10.1073/pnas.2002589117
25. Oudit GY, Crackower MA, Backx PH, Penninger JM, The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med 2003 13 93 101. doi: 10.1016/s1050-1738(02)00233-5
26. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002 417 822 828. doi: 10.1038/nature00786
27. Pedersen KB, Chodavarapu H, Porretta C, Robinson LK, Lazartigues E, Dynamics of ADAM17-mediated shedding of ACE2 applied to pancreatic islets of male db/db mice. Endocrinology 2015 156 4411 4425. doi: 10.1210/en.2015-1556
28. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, Batlle D, Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 2004 43 1120 1125. doi: 10.1161/01.HYP.0000126192.27644.76
29. Fagyas M, Úri K, Siket IM, Fülöp GÁ Csató V, Daragó A, Boczán J, Bányai E, Szentkirályi IE, Maros TM, New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human. PLoS One 2014 9 e87844. doi: 10.1371/journal.pone.0087844
30. Úri K, Fagyas M, Mányiné Siket I, Kertész A, Csanádi Z, Sándorfi G, Clemens M, Fedor R, Papp Z, Édes I, New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PLoS One 2014 9 e87845. doi: 10.1371/journal.pone.0087845
31. Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L, Sandholm N, Thomas MC, Groop PH, FinnDiane Study Group Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens 2012 30 375 383. doi: 10.1097/HJH.0b013e32834f04b6
32. Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 2010 107 888 897. doi: 10.1161/CIRCRESAHA.110.219279
33. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005 436 112 116. doi: 10.1038/nature03712
34. Wang K, Gheblawi M, Oudit GY, Angiotensin converting enzyme 2: a double-edged sword [published online March 26, 2020]. Circulation. doi: 10.1161/CIRCULATIONAHA.120.047049. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047049
35. Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pöhlmann S, Soilleux EJ, Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One 2012 7 e35876. doi: 10.1371/journal.pone.0035876
36. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, for the COVID-19 Lombardy ICU Network Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020 323 1574 1581. doi: 10.1001/jama.2020.5394
37. Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W, Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov 2020 6 11. doi: 10.1038/s41421-020-0147-1
38. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD, Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020 382 1653 1659. doi: 10.1056/NEJMsr2005760
39. Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, Widmer AF, Osswald S, SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J 2020 41 1801 1803. doi: 10.1093/eurheartj/ehaa235
40. Sagar S, Liu PP, Cooper LT Jr., Myocarditis. Lancet 2012 379 738 747. doi: 10.1016/S0140-6736(11)60648-X
41. Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Dilated cardiomyopathy. Nat Rev Dis Primers 2019 5 32. doi: 10.1038/s41572-019-0084-1
42. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Clinical and immunologic features in severe and moderate coronavirus disease 2019. J Clin Invest 2020 130 2620 2629. doi: 10.1172/JCI137244
43. Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, Song S, Ma Z, Mo P, Zhang Y, Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis 2020 221 1762 1769. doi: 10.1093/infdis/jiaa150
44. He Z, Zhao C, Dong Q, Zhuang H, Song S, Peng G, Dwyer DE, Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis 2005 9 323 330. doi: 10.1016/j.ijid.2004.07.014
45. Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, Chan PK, Ng MH, Yu LM, Hui DS, Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003 326 1358 1362. doi: 10.1136/bmj.326.7403.1358
46. Chen J, Lau YF, Lamirande EW, Paddock CD, Bartlett JH, Zaki SR, Subbarao K, Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol 2010 84 1289 1301. doi: 10.1128/JVI.01281-09
47. Fisman DN, Hemophagocytic syndromes and infection. Emerg Infect Dis 2000 6 601 608. doi: 10.3201/eid0606.000608
48. Pavlovich SS, Lovett SP, Koroleva G, Guito JC, Arnold CE, Nagle ER, Kulcsar K, Lee A, Thibaud-Nissen F, Hume AJ, The Egyptian Rousette genome reveals unexpected features of bat antiviral immunity. Cell 2018 173 1098 1110.e18. doi: 10.1016/j.cell.2018.03.070
49. Banerjee A, Falzarano D, Rapin N, Lew J, Misra V, Interferon regulatory factor 3-mediated signaling limits Middle-East respiratory syndrome (MERS) coronavirus propagation in cells from an insectivorous bat. Viruses 2019 11 152. doi: 10.3390/v11020152
50. Haagmans BL, Kuiken T, Martina BE, Fouchier RA, Rimmelzwaan GF, van Amerongen G, van Riel D, de Jong T, Itamura S, Chan KH, Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 2004 10 290 293. doi: 10.1038/nm1001
51. Acosta-Ramírez E, Pérez-Flores R, Majeau N, Pastelin-Palacios R, Gil-Cruz C, Ramírez-Saldaña M, Manjarrez-Orduño N, Cervantes-Barragán L, Santos-Argumedo L, Flores-Romo L, Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus. Immunology 2008 124 186 197. doi: 10.1111/j.1365-2567.2007.02753.x
52. Scheuplein VA, Seifried J, Malczyk AH, Miller L, Höcker L, Vergara-Alert J, Dolnik O, Zielecki F, Becker B, Spreitzer I, High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol 2015 89 3859 3869. doi: 10.1128/JVI.03607-14
53. Channappanavar R, Fehr AR, Zheng J, Wohlford-Lenane C, Abrahante JE, Mack M, Sompallae R, McCray PB Jr, Meyerholz DK, Perlman S, IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest 2019 130 3625 3639. doi: 10.1172/JCI126363
54. Simon AK, Hollander GA, McMichael A, Evolution of the immune system in humans from infancy to old age. Proc Biol Sci 2015 282 20143085. doi: 10.1098/rspb.2014.3085
55. Nencioni A, Trzeciak S, Shapiro NI, The microcirculation as a diagnostic and therapeutic target in sepsis. Intern Emerg Med 2009 4 413 418. doi: 10.1007/s11739-009-0297-5
56. Boisramé-Helms J, Kremer H, Schini-Kerth V, Meziani F, Endothelial dysfunction in sepsis. Curr Vasc Pharmacol 2013 11 150 160
57. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Covid-19 in critically ill patients in the Seattle region-case series. N Engl J Med 2020 382 2012 2022. doi: 10.1056/NEJMoa2004500
58. Valaperti A, Nishii M, Liu Y, Naito K, Chan M, Zhang L, Skurk C, Schultheiss HP, Wells GA, Eriksson U, Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production. Circulation 2013 128 1542 1554. doi: 10.1161/CIRCULATIONAHA.113.002275
59. Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, Yeh WC, Akira S, Liu PP, Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 2005 112 2276 2285. doi: 10.1161/CIRCULATIONAHA.105.536433
60. Opavsky MA, Martino T, Rabinovitch M, Penninger J, Richardson C, Petric M, Trinidad C, Butcher L, Chan J, Liu PP, Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 2002 109 1561 1569. doi: 10.1172/JCI13971
61. Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, Griffiths E, Krawczyk C, Richardson CD, Aitken K, CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001 409 349 354. doi: 10.1038/35053086
62. Liu P, Aitken K, Kong YY, Martino T, Dawood F, Wen WH, Opavsky MA, Kozieradzki I, Bachmaier K, Straus D, Essential role for the tyrosine kinase p56lck in coxsackievirus B3 mediated heart disease. Nature Med 2000 6 429 434
63. Xu M, Liu PP, Li H, Innate immune signaling and its role in metabolic and cardiovascular diseases. Physiol Rev 2019 99 893 948. doi: 10.1152/physrev.00065.2017
64. Epelman S, Liu PP, Mann DL, Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol 2015 15 117 129. doi: 10.1038/nri3800
65. Shi Y, Fukuoka M, Li G, Liu Y, Chen M, Konviser M, Chen X, Opavsky MA, Liu PP, Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway. Circulation 2010 121 2624 2634. doi: 10.1161/CIRCULATIONAHA.109.893248
66. Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018 72 3158 3176. doi: 10.1016/j.jacc.2018.09.072
67. Wang EY, Hulme OL, Khurshid S, Weng LC, Choi SH, Walkey AJ, Ashburner JM, McManus DD, Singer DE, Atlas SJ, Initial precipitants and recurrence of atrial fibrillation. Circ Arrhythm Electrophysiol 2020 13 e007716. doi: 10.1161/CIRCEP.119.007716
68. Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, Xu L, Li X, Liu H, Yin P, Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep 2017 7 9110. doi: 10.1038/s41598-017-09536-z